학술논문

Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic Review and Meta-Analysis.
Document Type
Article
Source
Open Forum Infectious Diseases. Jul2019, Vol. 6 Issue 7, pN.PAG-N.PAG. 1p.
Subject
*META-analysis
*LACTAMS
*THERAPEUTICS
*CEFTAZIDIME
*ENTEROBACTER
*SERRATIA
*CITROBACTER
Language
ISSN
2328-8957
Abstract
The optimal treatment for potential AmpC-producing Enterobacteriaceae , including Serratia, Providencia, Citrobacter, Enterobacter , and Morganella species, remains unknown. An updated systematic review and meta-analysis of studies comparing beta-lactam/beta-lactamase inhibitors with carbapenems in the treatment of bloodstream infections with these pathogens found no significant difference in 30-day mortality (OR, 1.13; 95% CI, 0.58 – 2.20). [ABSTRACT FROM AUTHOR]